XiFin to Highlight Impact of FDA Regulations, Other Disruptive Forces Facing Hospitals, Independent Labs, and Pathology Practices at 29th Annual Executive War College

XiFin Executive Chair and CEO Lâle White Keynote to Kick Off General Speaking Sessions As Industry Prepares for Critical Policy Changes

XiFin, Inc., a leading provider of innovative healthcare information technologies and services that deliver artificial intelligence (AI)-enabled operational efficiency, interoperability, and simplicity, will showcase forward-thinking insights, speaking at four sessions and two panels at the 29^th Annual Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management conference. Leveraging insights on big data gleaned from its experienced team of industry leading executives and award-winning platform, XiFin leaders plan to drive strategic, financial, and operational discussions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423862318/en/

XiFin Speakers: On left, Lâle White. From top left to right, Diana Richard, Stephanie Denham, Jeff Carmichael, Sandra Greefkes, Heather Agostinelli, and Clarisa Blattner. (Photo: Business Wire)

XiFin Executive Chair and CEO Lâle White will deliver a keynote focusing on the new regulations and market forces that will impact the diagnostic industry. Chief among these is the FDA’s bid for control of laboratory-developed tests (LDTs) and concerns surrounding Medicare Advantage programs. White aims to provide a grounding on these and other challenges to help attendees navigate the policy environment as they make institutional decisions in the coming year.

In addition, XiFin will share its new White Paper “Guide to AI-Enabled Revenue Cycle Management for Molecular Diagnostics and Pathology Practices” with all attendees. This paper demonstrates XiFin’s unique approach to facilitating organizational transition from complexity to clarity through AI-enabled workflows, which improve operational and financial performance, allowing customers to expand their impact in a timely manner. Furthermore, XiFin will reaffirm its commitment to innovation, expertise, and advocacy through focused initiatives that leverage big data, including XiFin’s Payor Rate Transparency Monitor and Lab Volume Index.

About XiFin

XiFin is a healthcare information technology company that empowers healthcare organizations to navigate an increasingly complex and evolving healthcare landscape. Through innovative AI-enabled technologies and services, we deliver operational efficiency, interoperability, and simplicity. The company’s revenue cycle management, clinical workflow enablement, laboratory information system, and patient engagement solutions enable organizations to achieve stronger finances, streamline operations, and develop industry-leading business strategies. XiFin solutions deliver THE POWER TO DO GOOD™ so that healthcare organizations can do more good for more patients. Visit www.XiFin.com, follow XiFin on LinkedIn, or subscribe to the XiFin blog to learn more.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240423862318/en/